The Report

Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses

8 reports and counting

Updated daily with latest market intelligence
Consumer Apps
MomentumWave Platform

MomentumWave Platform raises $112M Series D at $269M valuation

MomentumWave Platform secures $112M in Series D funding led by Paradigm, reaching $269M valuation as it accelerates growth in the consumer apps sector.

Alex Thompson
Jun 8, 2024
0 min readβ€’$112M
Enterprise Software
VelocityInnovate Platform

VelocityInnovate Platform raises $112M Series D at $278M valuation

VelocityInnovate Platform secures $112M in Series D funding led by GV (Google Ventures), reaching $278M valuation as it accelerates growth in the enterprise software sector.

Emily Johnson
Jun 8, 2024
0 min readβ€’$112M
EdTech
MomentumShift Platform

MomentumShift Platform raises $25M Series B at $112M valuation

MomentumShift Platform secures $25M in Series B funding led by Sequoia Capital, reaching $112M valuation as it accelerates growth in the edtech sector.

Alex Thompson
Aug 8, 2025
0 min readβ€’$25M
Fundraising
Rappi

Rappi Raises $112M in Debt

Rappi, a E-commerce company based in Bogota, Colombia, has raised $112M in Debt at a $5.25B valuation led by SoftBank, DST Global.

Fundraising News Team
Aug 25, 2024
0 min read
Fundraising
AdvanCell

AdvanCell Raises $112M in Series C

AdvanCell, a HealthTech company based in San Francisco, CA, has raised $112M in Series C at a $700M valuation led by Deerfield Management, Logos Capital.

Fundraising News Team
Feb 1, 2025
0 min read
HealthTech
AdvanCell

AdvanCell raises $112M Series C at $700M valuation

AdvanCell raises $112M in Series C at $700M valuation. Radionuclide cancer therapies...

Editorial Team
Feb 1, 2025
0 min readβ€’$112M
E-commerce
Rappi

Rappi raises $112M Debt at $5.25B valuation

Rappi raises $112M in Debt at $5.25B valuation. On-demand delivery super app for food, groceries, and retail...

Editorial Team
Aug 25, 2024
0 min readβ€’$112M
Biotech
ProfoundBio

ProfoundBio Raises $112M Series B

Clinical-stage oncology company developing antibody-drug conjugates (ADCs) for targeted cancer therapy

Sarah Kim
Oct 23, 2025
0 min readβ€’$112M Series B
Page 1

Showing 8 reports β€’ Page 1 β€’ Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.